Literature DB >> 30737488

Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research.

Nicholas A Turner1, Batu K Sharma-Kuinkel1, Stacey A Maskarinec1, Emily M Eichenberger1, Pratik P Shah1, Manuela Carugati1,2, Thomas L Holland1, Vance G Fowler3,4.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most successful modern pathogens. The same organism that lives as a commensal and is transmitted in both health-care and community settings is also a leading cause of bacteraemia, endocarditis, skin and soft tissue infections, bone and joint infections and hospital-acquired infections. Genetically diverse, the epidemiology of MRSA is primarily characterized by the serial emergence of epidemic strains. Although its incidence has recently declined in some regions, MRSA still poses a formidable clinical threat, with persistently high morbidity and mortality. Successful treatment remains challenging and requires the evaluation of both novel antimicrobials and adjunctive aspects of care, such as infectious disease consultation, echocardiography and source control. In this Review, we provide an overview of basic and clinical MRSA research and summarize the expansive body of literature on the epidemiology, transmission, genetic diversity, evolution, surveillance and treatment of MRSA.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30737488      PMCID: PMC6939889          DOI: 10.1038/s41579-018-0147-4

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  205 in total

1.  Methicillin-resistant Staphylococcus aureus colonization at different body sites: a prospective, quantitative analysis.

Authors:  Leonard A Mermel; Jennifer M Cartony; Pauline Covington; Gail Maxey; Dan Morse
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

2.  Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.

Authors:  Naval G Daver; Samuel A Shelburne; Robert L Atmar; Thomas P Giordano; Charles E Stager; Charles A Reitman; A Clinton White
Journal:  J Infect       Date:  2007-01-02       Impact factor: 6.072

Review 3.  Methicillin-resistant Staphylococcus aureus: the European landscape.

Authors:  Alan P Johnson
Journal:  J Antimicrob Chemother       Date:  2011-05       Impact factor: 5.790

Review 4.  Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology.

Authors:  Fred C Tenover; Richard V Goering
Journal:  J Antimicrob Chemother       Date:  2009-07-16       Impact factor: 5.790

Review 5.  Mobile genetic elements of Staphylococcus aureus.

Authors:  Natalia Malachowa; Frank R DeLeo
Journal:  Cell Mol Life Sci       Date:  2010-07-29       Impact factor: 9.261

6.  Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.

Authors:  Ari Robicsek; Jennifer L Beaumont; Richard B Thomson; Geetha Govindarajan; Lance R Peterson
Journal:  Infect Control Hosp Epidemiol       Date:  2009-07       Impact factor: 3.254

7.  Once-weekly dalbavancin versus daily conventional therapy for skin infection.

Authors:  Helen W Boucher; Mark Wilcox; George H Talbot; Sailaja Puttagunta; Anita F Das; Michael W Dunne
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

8.  Daptomycin therapy for osteomyelitis: a retrospective study.

Authors:  Jason C Gallagher; Jennifer A Huntington; Darren Culshaw; Scott A McConnell; Minjung Yoon; Elie Berbari
Journal:  BMC Infect Dis       Date:  2012-06-12       Impact factor: 3.090

9.  A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.

Authors:  Martin E Stryjewski; Arnold Lentnek; William O'Riordan; John Pullman; Paul Anantharajah Tambyah; Jose M Miró; Vance G Fowler; Steven L Barriere; Michael M Kitt; G Ralph Corey
Journal:  BMC Infect Dis       Date:  2014-05-23       Impact factor: 3.090

10.  Systematic Surveillance Detects Multiple Silent Introductions and Household Transmission of Methicillin-Resistant Staphylococcus aureus USA300 in the East of England.

Authors:  Michelle S Toleman; Sandra Reuter; Francesc Coll; Ewan M Harrison; Beth Blane; Nicholas M Brown; M Estée Török; Julian Parkhill; Sharon J Peacock
Journal:  J Infect Dis       Date:  2016-04-27       Impact factor: 5.226

View more
  214 in total

1.  Iridium piano stool complexes with activity against S. aureus and MRSA: it is past time to truly think outside of the box.

Authors:  Christine M DuChane; George W Karpin; Marion Ehrich; Joseph O Falkinham; Joseph S Merola
Journal:  Medchemcomm       Date:  2019-05-14       Impact factor: 3.597

2.  Characterization and complete genome analysis of Bacillus velezensis CB6 revealed ATP synthase subunit α against foodborne pathogens.

Authors:  Guan-Yi Xu; Haipeng Zhang; Changsi Mao; Yuxuan Xu; Wenlong Dong; Muhammad Inam; Siyu Pan; Renge Hu; Yiming Wang; Yu Wang; Hongxia Ma; Lingcong Kong
Journal:  Arch Microbiol       Date:  2020-11-04       Impact factor: 2.552

3.  Ability of Bicarbonate Supplementation To Sensitize Selected Methicillin-Resistant Staphylococcus aureus Strains to β-Lactam Antibiotics in an Ex Vivo Simulated Endocardial Vegetation Model.

Authors:  Arnold S Bayer; Selvi C Ersoy; Warren E Rose; Ana M Bienvenida; Yan Q Xiong; Henry F Chambers
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

4.  Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis.

Authors:  Vance G Fowler; Anita F Das; Joy Lipka-Diamond; Raymond Schuch; Roger Pomerantz; Luis Jáuregui-Peredo; Adam Bressler; David Evans; Gregory J Moran; Mark E Rupp; Robert Wise; G Ralph Corey; Marcus Zervos; Pamela S Douglas; Cara Cassino
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

5.  Exploration of the Structural Space in 4(3H)-Quinazolinone Antibacterials.

Authors:  Yuanyuan Qian; Giuseppe Allegretta; Jeshina Janardhanan; Zhihong Peng; Kiran V Mahasenan; Elena Lastochkin; Melissa Malia N Gozun; Sara Tejera; Valerie A Schroeder; William R Wolter; Rhona Feltzer; Shahriar Mobashery; Mayland Chang
Journal:  J Med Chem       Date:  2020-05-08       Impact factor: 7.446

Review 6.  Constructing and deconstructing the bacterial cell wall.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Protein Sci       Date:  2019-11-20       Impact factor: 6.725

7.  Dramatic Changes in Oligomerization Property Caused by Single Residue Deletion in Staphylococcus aureus Enolase.

Authors:  Vijay Hemmadi; Malabika Biswas
Journal:  Mol Biotechnol       Date:  2021-01-01       Impact factor: 2.695

Review 8.  Antimicrobial Resistance in ESKAPE Pathogens.

Authors:  David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

9.  Molecular reprogramming and phenotype switching in Staphylococcus aureus lead to high antibiotic persistence and affect therapy success.

Authors:  Markus Huemer; Srikanth Mairpady Shambat; Judith Bergada-Pijuan; Sandra Söderholm; Mathilde Boumasmoud; Clément Vulin; Alejandro Gómez-Mejia; Minia Antelo Varela; Vishwachi Tripathi; Sandra Götschi; Ewerton Marques Maggio; Barbara Hasse; Silvio D Brugger; Dirk Bumann; Reto A Schuepbach; Annelies S Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

10.  Inhibition of the ULK1 protein complex suppresses Staphylococcus-induced autophagy and cell death.

Authors:  Ohood A Radhi; Scott Davidson; Fiona Scott; Run X Zeng; D Heulyn Jones; Nicholas C O Tomkinson; Jun Yu; Edmond Y W Chan
Journal:  J Biol Chem       Date:  2019-08-06       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.